Concurrent cisplatin and radiotherapy in advanced head and neck cancer

被引:4
|
作者
Rehan Asif
Kamlesh Chandra
Vanita Chopra
M. L. B. Bhatt
机构
[1] Deptt of Otorhmolaryngology,Deptt of Radiotherapy
[2] J N M C Hospital,undefined
[3] A.M U,undefined
关键词
Neck Cancer; Bleomycin; Local Tumor Control; Local Tumor Recurrence; Concomitant Chemotherapy;
D O I
10.1007/BF02974612
中图分类号
学科分类号
摘要
Management of Head and Neck Cancers poses a challenge inspite of several advances because of poor success in terms of response rate, survival and reduced morbidity of the patients. In the present study 30 untreated histologically proven cases of head and neck cancers were subjected to weekly radiotherapy with adjuvant chemotherapy (cisplatin 30 mg/m2 intravenously). This study group was compared with a group of 30 patients who were given only radiotherapy. Results have shown that combination of chemotherapy with radiotherapy gives a significantly better results in tumour as well as nodal response with minimal toxicities.
引用
收藏
页码:94 / 96
页数:2
相关论文
共 50 条
  • [41] COMBINED CHEMOTHERAPY AND RADIOTHERAPY IN THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER USING CISPLATIN
    BAUMOHL, J
    KLIMO, J
    ANDRASINA, I
    JUTKA, K
    NEOPLASMA, 1987, 34 (04) : 497 - 502
  • [42] Concomitant Weekly Cisplatin and Altered Fractionation Radiotherapy in Locally Advanced Head and Neck Cancer
    Newlin, Heather E.
    Amdur, Robert J.
    Riggs, Charles E.
    Morris, Christopher G.
    Kirwan, Jessica M.
    Mendenhall, William M.
    CANCER, 2010, 116 (19) : 4533 - 4540
  • [43] Radiotherapy and concurrent low-dose paclitaxel in locally advanced head and neck cancer
    Lövey, J
    Koronczay, K
    Remenár, É
    Csuka, O
    Németh, G
    RADIOTHERAPY AND ONCOLOGY, 2003, 68 (02) : 171 - 174
  • [44] INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER
    Barone, C.
    Birocco, N.
    Ritta, M.
    Rampino, M.
    RuoRedda, M. G.
    Ricardi, U.
    Bertetto, O.
    Schena, M.
    ANNALS OF ONCOLOGY, 2004, 15 : 30 - 30
  • [45] Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study
    Karasawa, Kumiko
    Matsumoto, Fumihiko
    Ito, Sin
    Oba, Sinichi
    Furuya, Tomohisa
    Hirowatari, Hisako
    Izawa, Hiromi
    Ito, Kana
    Sasai, Keisuke
    ANTICANCER RESEARCH, 2012, 32 (09) : 4013 - 4018
  • [46] Radiotherapy compliance is maintained with hyprofractionation and concurrent cetuximab in locally advanced head and neck cancer
    Chan, Andrew
    Teoh, Daien
    Singhera, Paul
    Hartley, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 654 - 654
  • [47] Concomitant Weekly Cisplatin and Radiotherapy for Head and Neck Cancer
    Homma, Akihiro
    Inamura, Naoya
    Oridate, Nobuhiko
    Suzuki, Seigo
    Hatakeyama, Hiromitsu
    Mizumachi, Takatsugu
    Kano, Satoshi
    Sakashita, Tomohiro
    Onimaru, Rikiya
    Yasuda, Koichi
    Shirato, Hiroki
    Fukuda, Satoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 980 - 986
  • [48] Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer
    Karasawa, K
    Shinoda, H
    Katsui, K
    Seki, K
    Kohno, M
    Hanyu, N
    Nasu, S
    Muramatsu, H
    Maebayashi, K
    Mitsuhashi, N
    Yoshihara, T
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3785 - 3788
  • [49] Concurrent chemoradiotherapy with cisplatin and docetaxel for advanced head and neck cancer. A phase I study
    Inohara, H
    Inoue, T
    Akahani, S
    Yamamoto, Y
    Takenaka, Y
    Nakagawa, T
    Isohashi, F
    Kubo, T
    ANTICANCER RESEARCH, 2004, 24 (06) : 4135 - 4140
  • [50] Concurrent chemoradiation with daily low dose cisplatin in advanced stage head and neck cancer patients
    Hoebers, F
    Balm, AJ
    Schornagel, JH
    Rasch, CRN
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S305 - S305